Matropin Ophthalmic Solution 2%
Matropin Ophthalmic Solution 2% Uses, Dosage, Side Effects, Food Interaction and all others data.
| Trade Name | Matropin Ophthalmic Solution 2% |
| Generic | Homatropine Hydrobromide |
| Weight | 2% |
| Type | Ophthalmic Solution |
| Therapeutic Class | Mydriatic and Cycloplegic agents |
| Manufacturer | Aristopharma Ltd. |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Uses
Matropin Ophthalmic Solution 2% sterile Eye Drops is indicated for use as a mydriatic and cycloplegic agent.Dosage
Matropin Ophthalmic Solution 2% dosage
Mydriasis and cycloplegia for refraction: Adult: Instill 1 or 2 drops of 2% solution, or 1 drop of 5% solution immediately before the procedure, repeat at 5-10 minute intervals if necessary. Child: Instill 1 drop of 2% soln immediately before the procedure, repeat at 10-min intervals if necessary. Uveitis: Adult: Instill 1-2 drops of 2% or 5% solution bid-tid up to every 3-4 hr as needed. Child: 3 mth- 2 yr: instill 1 drop of 0.5% soln once daily or on alternate days. >2 yr: instill 1 drop of 1% or 2% soln bid.Side Effects
Hypersensitivity may occur as conjunctivitis.Precaution
Should be used with caution in patients with prostatic enlargement and in patients suffering from paralytic ileus or pyloric stenosis.Interaction
Effects may be increased by drugs with antimuscarinic effect such as; some antihistamines; phenothiazines; antipsychotics; TCAs; MAOIs or parasympathomimetics.Pregnancy & Breastfeeding use
Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. Matropin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Use in lactation: It is not known whether Homatropine is excreted in human milk. Caution should be exercised when Matropin is administered to a nursing mother.Contraindication
Contraindicated in patients with closed-angle glaucoma or with a narrow angle between the iris and the cornea.Special Warning
Use in children: Should not be used in children below the age of 3 monthsAcute Overdose
Ataxia, incoherent speech, restlessness, hallucinations, disorientation, failure to recognize people and tachycardia. Psychotic reactions and behavioural disturbances (in children). SC/IM/IV Physostigmine salicylate 1-2 mg to control central and peripheral effects. Small doses of short-acting barbiturate eg. thiopentone sodium 100 mg to control excitement.Innovators Monograph
You find simplified version here Matropin Ophthalmic Solution 2%
